Cosmo N.V. (SWX: CMHC)
Health Care · Pharmaceuticals · IE
CHF52.50
-1.32% today · -22.2% 1Y
Cosmo N.V. (SWX: CMHC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.09B and employs 3,245 people.
Over the last twelve months the share price has lost 22.2%, trading between 51.70 and 129.40.
Tweenvest scores Cosmo N.V. across four factors: quality 67/100, value 62/100, growth 26/100, dividend 69/100. Its strongest factor is dividend.
CMHC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.09B
- Revenue (TTM)
- $117.32M
- P/E
- —
- EPS
- -0.38
- Dividend yield
- 3.69%
- Beta (5Y)
- 1.46
- 52-week high
- CHF129.40
- 52-week low
- CHF51.70
- Avg volume (3M)
- —
- Shares outstanding
- 17.19M
- Employees
- 3,245
- Next earnings
- —
About Cosmo N.V.
Cosmo NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
- ISIN
- NL0011832936
- Founded
- 1997
- Listed since
- Mar 12, 2007
- Exchange
- SIX Swiss Exchange
- Currency
- CHF
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Chongqing Taiji Industry(Group) Co.,LtdSHSE: 600129 | $1.11B | CN¥13.54 | +1.58% |
| Jiuzhitang Co., Ltd.SZSE: 000989 | $1.10B | CN¥8.75 | +2.70% |
| Towa Pharmaceutical Co., Ltd.TSE: 4553 | $1.09B | ¥3,495.00 | -5.80% |
| Tianjin Tianyao Pharmaceuticals Co., Ltd.SHSE: 600488 | $1.09B | CN¥6.69 | +17.37% |
| Amphastar Pharmaceuticals, Inc.NasdaqGS: AMPH | $1.08B | $25.43 | +0.32% |
| Renhe Pharmacy Co.,LtdSZSE: 000650 | $1.08B | CN¥5.24 | +2.14% |
| Suzhou Highfine Biotech Co., Ltd.SZSE: 301393 | $1.07B | CN¥67.13 | +0.22% |
| Guilin Sanjin Pharmaceutical Co., Ltd.SZSE: 002275 | $1.07B | CN¥12.22 | +0.99% |
Figures last refreshed Sep 27, 2026.